Projected Income Statement: CellaVision AB

Forecast Balance Sheet: CellaVision AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 6.37 -5.56 -56.9 -123 -163 -216 -261 -326
Change - -187.28% -923.38% -116.17% -32.52% -32.87% -20.83% -24.9%
Announcement Date 2/4/22 2/8/23 2/7/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Cash Flow Forecast: CellaVision AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 84.34 70.01 85.53 76.01 86.26 75.65 80.22 84.72
Change - -16.99% 22.16% -11.14% 13.48% -12.29% 6.05% 5.61%
Free Cash Flow (FCF) 1 114.2 67.27 110.9 122.4 114.3 107.6 122.1 147.8
Change - -41.09% 64.86% 10.39% -6.66% -5.82% 13.47% 21.02%
Announcement Date 2/4/22 2/8/23 2/7/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Forecast Financial Ratios: CellaVision AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 34.69% 31.03% 30.54% 30.24% 31.8% 29.16% 30.91% 31.72%
EBIT Margin (%) 28.77% 24.75% 24.66% 24.57% 26.62% 23.31% 25.59% 26.76%
EBT Margin (%) 27.99% 23.22% 24.25% 24.45% 25.6% 23.18% 25.45% 26.63%
Net margin (%) 22.16% 18.51% 19.24% 19.46% 20.17% 18.36% 20.5% 21.69%
FCF margin (%) 20.19% 10.52% 16.37% 16.93% 15.06% 14% 14.17% 15.55%
FCF / Net Income (%) 91.11% 56.85% 85.11% 87% 74.65% 76.23% 69.14% 71.69%

Profitability

        
ROA - 13.78% 14.32% - - - - -
ROE 25.77% 19.97% 19.19% 18.37% 18% 16.05% 17.73% 18.45%

Financial Health

        
Leverage (Debt/EBITDA) 0.03x - - - - - - -
Debt / Free cash flow 0.06x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 14.91% 10.95% 12.63% 10.51% 11.36% 9.84% 9.31% 8.91%
CAPEX / EBITDA (%) 42.99% 35.3% 41.36% 34.76% 35.73% 33.74% 30.12% 28.1%
CAPEX / FCF (%) 73.85% 104.08% 77.12% 62.08% 75.48% 70.29% 65.69% 57.32%

Items per share

        
Cash flow per share 1 - - - - 8.407 7.7 8.5 9.8
Change - - - - - -8.41% 10.39% 15.29%
Dividend per Share 1 2 2 2.25 2.5 2.75 2.75 3.075 3.362
Change - 0% 12.5% 11.11% 10% 0% 11.82% 9.35%
Book Value Per Share 1 22.78 26.9 30.04 34.2 37.21 41.17 45.6 50.82
Change - 18.09% 11.67% 13.85% 8.8% 10.64% 10.75% 11.45%
EPS 1 5.25 4.96 5.46 5.9 6.42 5.924 7.239 8.349
Change - -5.52% 10.08% 8.06% 8.81% -7.73% 22.2% 15.34%
Nbr of stocks (in thousands) 23,852 23,852 23,852 23,852 23,852 23,852 23,852 23,852
Announcement Date 2/4/22 2/8/23 2/7/24 2/6/25 2/5/26 - - -
1SEK
Estimates
2026 *2027 *
P/E 23x 18.8x
PBR 3.3x 2.98x
EV / Sales 3.94x 3.46x
Yield 2.02% 2.26%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
136.00SEK
Average target price
177.75SEK
Spread / Average Target
+30.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
  4. Financials CellaVision AB